Literature DB >> 28110836

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab.

Nabil Adra1, Liang Cheng2, Roberto Pili3.   

Abstract

Entities:  

Keywords:  Immunotherapy; Kidney cancer; Therapeutic; Unclassified renal cancer; Undifferentiated

Mesh：

Substances：

Year:  2016        PMID： 28110836     DOI： 10.1016/j.clgc.2016.12.019

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  2 in total

Review 1.  Integrating Immunotherapy Into the Management of Renal Cell Carcinoma.

Authors:  Matthew Zibelman; Elizabeth R Plimack
Journal:  J Natl Compr Canc Netw       Date:  2017-06       Impact factor: 11.908

2.  Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report.

Authors:  Go Noguchi; Sohgo Tsutsumi; Masato Yasui; Shinji Ohtake; Susumu Umemoto; Noboru Nakaigawa; Masahiro Yao; Takeshi Kishida
Journal:  BMC Urol       Date:  2018-04-18       Impact factor: 2.264
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.